Celltrion Wins Successive Bids in Italian Regional Drug Tenders
Celltrion is expanding its presence in Italy as its autoimmune disease treatments and cancer therapies continue to secure…
Remsima
4 개의 기사가 있습니다.
Celltrion “Remsima SC captures 22% market share in Europe”
Celltrion’s Remsima SC is solidifying its position as a leading autoimmune disease treatment in Europe. On May 28,…
Celltrion’s Achievement: Remsima Becomes Korea’s First Global Blockbuster Drug
Celltrion's autoimmune disease treatment, Remsima (ingredient: infliximab), has surpassed annual sales of 1.2 trillion KRW, becoming Korea’s first…
Celltrion Establishes Subsidiary in Vietnam
Celltrion has officially entered the ASEAN market by establishing a local subsidiary in Vietnam. Following the company's tradition…